XML 45 R34.htm IDEA: XBRL DOCUMENT v3.26.1
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
The following table presents share-based compensation expense and the related tax benefits for the periods indicated:
Three Months Ended June 30,
Six Months Ended June 30,
($ in thousands)
2026
2025
2026
2025
Share-based compensation expense related to:
Stock options
$68 $69 $134 $137 
Restricted stock awards
165 163 329 325 
Total share-based compensation expense
$233 $232 $463 $462 
Related tax benefits
$63 $61 $124 $122 
The following table presents unrecognized share-based compensation expense as of the date indicated:
June 30, 2026
($ in thousands)Unrecognized ExpenseWeighted-Average Remaining Expected Recognition Period
Unrecognized share-based compensation expense related to:
Stock options
$141 1.7 years
Restricted stock awards
1,393 2.4 years
Total unrecognized share-based compensation expense
$1,534 2.3 years
Schedule of Stock Options
The following tables represent stock option activity for the periods indicated:
Three Months Ended June 30, 2026
($ in thousands except per share data)
Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Contractual TermAggregated Intrinsic Value
Outstanding at beginning of period
359,680 $16.11 5.50 years$2,295 
Granted
5,000 $24.33 10.00 years
Exercised
(12,200)$16.44 3.05 years
Outstanding at end of period
352,480 $16.21 5.40 years$4,285 
Exercisable at end of period
255,161 $16.15 4.67 years$3,118 
Six Months Ended June 30, 2026
($ in thousands except per share data)
Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Contractual TermAggregated Intrinsic Value
Outstanding at beginning of period369,680 $15.98 5.73 years$2,097 
Granted5,000 $24.33 10.00 years
Exercised(22,200)$14.08 3.89 years
Outstanding at end of period352,480 $16.21 5.40 years$4,285 
Exercisable at end of period255,161 $16.15 4.67 years$3,118 
The following table represents information regarding unvested stock options for the periods indicated:
Three Months Ended June 30, 2026
Six Months Ended June 30, 2026
Number of SharesWeighted-Average Exercise Price Per ShareNumber of SharesWeighted-Average Exercise Price Per Share
Outstanding at beginning of period
92,319 $15.95 98,319 $16.16 
Granted
5,000 $24.33 5,000 $24.33 
Vested— $— (6,000)$19.46 
Outstanding at end of period
97,319 $16.38 97,319 $16.38 
Schedule of Restricted Stock Awards
The following table represents restricted stock award activity for the periods indicated:
Three Months Ended June 30, 2026
Six Months Ended June 30, 2026
Number of SharesWeighted-Average Grant Date Fair Value Per ShareNumber of SharesWeighted-Average Grant Date Fair Value Per Share
Outstanding at beginning of period
85,850 $20.43 90,850 $20.52 
Vested— $— (5,000)$21.96 
Outstanding at end of period
85,850 $20.43 85,850 $20.43